Xos, Inc.
US ˙ NasdaqCM ˙ US98423B1089

Introduction

This page provides a comprehensive analysis of the known insider trading history of Edward J Rapp. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Edward J Rapp has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:XOS / Xos, Inc. Director 121,894
US:ABBV / AbbVie Inc. Director 34,458
US:CAT / Caterpillar Inc. Group President 114,049
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Edward J Rapp. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases XOS / Xos, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in XOS / Xos, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-11-30 XOS RAPP EDWARD J 300,000 0.6900 10,000 20.7000 207,000 42 32.4 117,000 56.52
2021-11-18 XOS RAPP EDWARD J 100,000 4.2682 3,333 128.0460 426,820
2021-09-01 XOS RAPP EDWARD J 5,000 6.6500 167 199.5000 33,250

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XOS / Xos, Inc. Insider Trades
Insider Sales XOS / Xos, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in XOS / Xos, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XOS / Xos, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Edward J Rapp as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-14 2025-07-10 4 XOS Xos, Inc.
Common Stock
A - Award 1,601 121,894 1.33
2025-07-14 2025-07-10 4 XOS Xos, Inc.
Common Stock
A - Award 62,377 120,293 107.70
2025-05-13 2025-05-09 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,203 34,458 3.62
2025-04-30 2025-04-10 4 XOS Xos, Inc.
Common Stock
A - Award 1,407 57,916 2.49
2025-02-26 2025-01-10 4/A XOS Xos, Inc.
Common Stock
A - Award 1,475 56,509 2.68
2025-01-14 2025-01-10 4 XOS Xos, Inc.
Common Stock
A - Award 1,065 56,099 1.94
2024-12-17 2024-10-10 4 XOS Xos, Inc.
Common Stock
A - Award 1,065 55,034 1.97
2024-07-12 2024-07-10 4 XOS Xos, Inc.
Common Stock
A - Award 717 53,969 1.35
2024-07-12 2024-07-10 4 XOS Xos, Inc.
Common Stock
A - Award 28,694 53,252 116.84
2024-05-07 2024-05-03 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,322 31,356 4.40
2024-04-12 2024-04-10 4 XOS Xos, Inc.
Common Stock
A - Award 445 24,558 1.85
2024-01-17 2024-01-15 4 XOS Xos, Inc.
Common Stock
A - Award 650 24,113 2.77
2023-10-12 2023-10-10 4 XOS Xos, Inc.
Common Stock
A - Award 15,151 703,915 2.20
2023-07-13 2023-07-12 4 XOS Xos, Inc.
Common Stock
A - Award 15,151 688,764 2.25
2023-06-14 2023-06-12 4 XOS Xos, Inc.
Common Stock
A - Award 444,444 673,613 193.94
2023-05-09 2023-05-05 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,450 30,034 5.07
2023-04-04 2023-04-03 4 XOS Xos, Inc.
Common Stock
A - Award 7,936 229,169 3.59
2023-01-12 2023-01-10 4 XOS Xos, Inc.
Common Stock
A - Award 7,936 521,233 1.55
2022-12-02 2022-11-30 4 XOS Xos, Inc.
Common Stock
P - Purchase 300,000 513,297 140.65 0.69 207,000 354,175
2022-10-04 2022-09-30 4 XOS Xos, Inc.
Common Stock
A - Award 3,378 213,297 1.61
2022-09-14 2022-09-12 4 XOS Xos, Inc.
Common Stock
A - Award 115,606 209,919 122.58
2022-08-05 2022-08-03 4 XOS Xos, Inc.
Common Stock
A - Award 3,816 94,313 4.22
2022-05-09 2022-05-06 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,421 28,584 5.23
2022-04-04 2022-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 217 21,860 1.00 162.11 35,178 3,543,725
2022-01-04 2021-12-31 4 XOS Xos, Inc.
Common Stock
A - Award 1,474 1,474
2022-01-04 2021-12-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 260 21,434 1.23 135.40 35,204 2,902,164
2021-11-22 2021-11-18 4 XOS Xos, Inc.
Common Stock
P - Purchase 100,000 335,169 42.52 4.27 426,820 1,430,568
2021-11-15 2021-11-10 4 XOS Xos, Inc.
Restricted Stock Unit
A - Award 31,794 31,794
2021-11-15 2021-11-10 4 XOS Xos, Inc.
Restricted Stock Unit
A - Award 57,229 57,229
2021-10-04 2021-09-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 326 20,941 1.58 107.87 35,166 2,258,906
2021-09-02 2021-09-01 4 XOS Xos, Inc.
Common Stock
P - Purchase 5,000 235,169 2.17 6.65 33,250 1,563,874
2021-08-24 3 XOS Xos, Inc.
No securities owned.
0
2021-08-24 2021-08-20 4 XOS Xos, Inc.
Common Stock
A - Award 230,169 230,169
2021-07-02 2021-06-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 312 20,390 1.55 112.67 35,153 2,297,341
2021-05-11 2021-05-07 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,681 27,163 6.60
2021-04-01 2021-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 325 19,855 1.66 108.22 35,172 2,148,708
2021-01-05 2020-12-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 328 19,289 1.73 107.05 35,112 2,064,887
2020-10-02 2020-09-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 402 18,735 2.19 87.59 35,211 1,640,999
2020-10-02 2020-09-03 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
G - Gift 7,513 10,388 261.32
2020-10-02 2020-09-03 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
G - Gift -7,513 25,482 -22.77
2020-07-02 2020-06-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 350 18,108 1.97 98.18 34,363 1,777,843
2020-05-12 2020-05-08 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 2,333 32,995 7.61
2020-04-02 2020-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 446 17,530 2.61 76.19 33,981 1,335,611
2020-03-04 2020-03-03 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
P - Purchase 2,875 2,875 87.87 252,617 252,617
2020-01-03 2019-12-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 384 16,872 2.33 88.54 33,999 1,493,847
2019-10-01 2019-09-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 449 16,291 2.83 75.72 33,998 1,233,555
2019-07-02 2019-06-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 467 15,577 3.09 72.72 33,960 1,132,759
2019-06-28 2019-06-26 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
P - Purchase 7,500 30,662 32.38 67.30 504,750 2,063,553
2019-05-07 2019-05-03 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 2,419 23,162 11.66
2019-04-02 2019-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 421 14,907 2.91 80.59 33,928 1,201,355
2019-01-03 2018-12-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 368 14,296 2.64 92.19 33,926 1,317,948
2018-10-02 2018-09-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 359 13,780 2.67 94.58 33,954 1,303,312
2018-07-02 2018-06-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 357 13,290 2.76 92.65 33,076 1,231,318
2018-06-22 2018-06-20 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
P - Purchase 1,013 20,743 5.13 98.63 99,909 2,045,812
2018-05-07 2018-05-04 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 1,899 17,629 12.07
2018-04-02 2018-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 346 12,814 2.78 94.65 32,749 1,212,845
2018-01-03 2017-12-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 338 12,391 2.80 96.71 32,688 1,198,334
2017-10-03 2017-09-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 368 11,971 3.17 88.86 32,700 1,063,743
2017-08-02 2017-07-31 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
P - Purchase 4,000 15,498 34.79 70.45 281,782 1,091,764
2017-07-05 2017-06-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 451 11,498 4.08 72.51 32,702 833,720
2017-05-09 2017-05-05 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 2,770 15,730 21.37
2017-04-04 2017-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 502 10,941 4.81 65.16 32,710 712,916
2017-01-04 2016-12-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 523 10,331 5.33 62.62 32,750 646,927
2016-10-04 2016-09-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 519 9,720 5.64 63.07 32,733 613,040
2016-07-15 2016-06-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 531 9,124 6.18 61.91 32,874 564,867
2016-05-10 2016-05-06 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 2,974 12,960 29.78
2016-04-04 2016-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 577 8,514 7.27 57.12 32,958 486,320
2016-03-09 2016-03-07 4 CAT CATERPILLAR INC
Employee Stock Option
A - Award 114,049 114,049
2016-01-05 2015-12-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 557 7,853 7.63 59.24 32,997 465,212
2015-10-02 2015-09-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 606 7,234 9.14 54.41 32,972 393,602
2015-07-02 2015-06-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 491 6,579 8.07 67.19 32,990 442,043
2015-05-12 2015-05-08 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 2,187 9,986 28.04
2015-05-05 2015-05-02 4 CAT CATERPILLAR INC
Restricted Stock Units
M - Exercise -334 332 -50.15
2015-05-05 2015-05-02 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -153 70,315 -0.22 87.56 -13,397 6,157,133
2015-05-05 2015-05-02 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 334 70,850 0.47
2015-05-05 2015-05-01 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -382 70,468 -0.54 87.52 -33,433 6,167,359
2015-04-02 2015-04-01 4 CAT CATERPILLAR INC
Restricted Stock Units
M - Exercise -391 0 -100.00
2015-04-02 2015-04-01 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -179 72,892 -0.24 79.96 -14,312 5,828,080
2015-04-02 2015-04-01 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 391 73,071 0.54
2015-04-02 2015-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 563 6,041 10.28 58.54 32,958 353,640
2015-03-04 2015-03-02 4 CAT CATERPILLAR INC
Employee Stock Option
A - Award 172,621 172,621
2015-01-05 2014-12-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 504 5,432 10.23 65.44 32,982 355,470
2014-10-02 2014-09-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 571 4,896 13.20 57.76 32,981 282,793
2014-08-07 2014-08-05 4 CAT CATERPILLAR INC
Employee Stock Option
M - Exercise -30,000 0 -100.00
2014-08-07 2014-08-05 4 CAT CATERPILLAR INC
Common Stock
S - Sale -15,000 74,180 -16.82 101.01 -1,515,150 7,492,922
2014-08-07 2014-08-05 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -10,614 89,180 -10.64 101.70 -1,079,497 9,070,052
2014-08-07 2014-08-05 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 30,000 99,794 42.98 45.64 1,369,275 4,554,848
2014-08-07 2014-06-26 4 CAT CATERPILLAR INC
Common Stock
G - Gift -1,500 72,680 -2.02
2014-08-07 2014-05-06 4/A CAT CATERPILLAR INC
Common Stock
S - Sale -15,000 69,794 -17.69 103.99 -1,559,790 7,257,599
2014-08-07 2014-05-06 4/A CAT CATERPILLAR INC
Common Stock
M - Exercise 15,000 84,794 21.49 45.64 684,638 3,870,210
2014-08-07 2014-05-06 4/A CAT CATERPILLAR INC
Common Stock
F - Taxes -10,534 69,794 -13.11 104.04 -1,095,905 7,261,019
2014-08-07 2014-05-06 4/A CAT CATERPILLAR INC
Common Stock
M - Exercise 15,000 80,328 22.96 45.64 684,638 3,666,371
2014-07-02 2014-06-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 584 4,291 15.75 56.44 32,961 242,184
2014-05-13 2014-05-09 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 2,764 7,799 54.90
2014-05-07 2014-05-06 4 CAT CATERPILLAR INC
Employee Stock Option
M - Exercise -30,000 30,000 -50.00
2014-05-07 2014-05-06 4 CAT CATERPILLAR INC
Common Stock
S - Sale -15,000 65,485 -18.64 103.99 -1,559,790 6,809,523
2014-05-07 2014-05-06 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 15,000 80,485 22.91 45.64 684,638 3,673,537
2014-05-07 2014-05-06 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 15,000 80,485 22.91 45.64 684,638 3,673,537
2014-05-07 2014-05-06 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -10,534 65,485 -13.86 104.04 -1,095,905 6,812,732
2014-05-06 2014-05-02 4 CAT CATERPILLAR INC
Restricted Stock Units
M - Exercise -334 666 -33.40
2014-05-06 2014-05-02 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -157 65,328 -0.24 105.16 -16,509 6,869,566
2014-05-06 2014-05-02 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 334 65,485 0.51
2014-04-02 2014-04-01 4 CAT CATERPILLAR INC
Restricted Stock Units
M - Exercise -392 391 -50.06
2014-04-02 2014-04-01 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -185 65,151 -0.28 99.51 -18,409 6,483,176
2014-04-02 2014-04-01 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 392 65,336 0.60
2014-04-02 2014-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 642 3,677 21.15 51.40 32,999 188,998
2014-03-05 2014-03-03 4 CAT CATERPILLAR INC
Employee Stock Option
A - Award 86,742 86,742
2014-02-27 2014-01-31 4/A CAT CATERPILLAR INC
Employee Stock Option
M - Exercise -60,000 0 -100.00
2014-02-27 2014-01-31 4/A CAT CATERPILLAR INC
Common Stock
S - Sale -30,000 64,944 -31.60 94.24 -2,827,098 6,120,102
2014-02-27 2014-01-31 4/A CAT CATERPILLAR INC
Common Stock
M - Exercise 30,000 94,944 46.19 38.63 1,158,825 3,667,449
2014-02-27 2014-01-31 4/A CAT CATERPILLAR INC
Common Stock
F - Taxes -20,671 64,944 -24.14 93.35 -1,929,638 6,062,522
2014-02-27 2014-01-31 4/A CAT CATERPILLAR INC
Common Stock
M - Exercise 30,000 85,615 53.94 38.63 1,158,825 3,307,093
2014-02-04 2014-01-31 4 CAT CATERPILLAR INC
Employee Stock Option
M - Exercise -60,000 0 -100.00
2014-02-04 2014-01-31 4 CAT CATERPILLAR INC
Common Stock
S - Sale -30,000 65,824 -31.31 94.24 -2,827,098 6,203,030
2014-02-04 2014-01-31 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 30,000 95,824 45.58 38.63 1,158,825 3,701,442
2014-02-04 2014-01-31 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 30,000 95,824 45.58 38.63 1,158,825 3,701,442
2014-02-04 2014-01-31 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -19,791 65,824 -23.12 93.35 -1,847,490 6,144,670
2014-01-03 2013-12-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 624 3,011 26.14 52.81 32,953 159,011
2013-10-02 2013-09-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 737 2,367 45.21 44.73 32,966 105,876
2013-07-01 2013-06-30 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 798 1,614 97.79 41.34 32,989 66,723
2013-05-08 2013-05-06 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
A - Award 2,535 5,035 101.40
2013-04-03 2013-04-01 4 CAT CATERPILLAR INC
Restricted Stock Units
M - Exercise -392 783 -33.36
2013-04-03 2013-04-01 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -185 55,570 -0.33 86.18 -15,942 4,788,745
2013-04-03 2013-04-01 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 392 55,755 0.71
2013-04-03 2013-04-01 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -78 55,363 -0.14 86.18 -6,722 4,770,907
2013-04-02 2013-03-31 4 ABBV AbbVie Inc.
Stock Equivalent Units
A - Award 809 809 40.78 32,991 32,991
2013-03-12 2013-03-11 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
P - Purchase 600 2,500 31.58 37.67 22,600 94,168
2013-03-12 2013-03-11 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
P - Purchase 100 1,900 5.56 37.66 3,766 71,561
2013-03-12 2013-03-11 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
P - Purchase 100 1,800 5.88 37.67 3,767 67,798
2013-03-12 2013-03-11 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
P - Purchase 100 1,700 6.25 37.66 3,766 64,030
2013-03-12 2013-03-11 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
P - Purchase 100 1,600 6.67 37.66 3,766 60,256
2013-03-12 2013-03-11 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
P - Purchase 100 1,500 7.14 37.66 3,766 56,492
2013-03-12 2013-03-11 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
P - Purchase 200 1,400 16.67 37.66 7,533 52,730
2013-03-12 2013-03-11 4 ABBV AbbVie Inc.
Common stock, $0.01 par value
P - Purchase 1,200 1,200 37.67 45,204 45,204
2013-03-06 2013-03-04 4 CAT CATERPILLAR INC
Common Stock
F - Taxes -1,530 55,441 -2.69 91.04 -139,299 5,047,626
2013-03-06 2013-03-01 4 CAT CATERPILLAR INC
Restricted Stock Units
M - Exercise -3,257 0 -100.00
2013-03-06 2013-03-01 4 CAT CATERPILLAR INC
Common Stock
M - Exercise 3,257 56,971 6.06
2013-03-05 2013-03-04 4 CAT CATERPILLAR INC
Employee Stock Option (right to buy)
A - Award 79,976 79,976
2012-12-20 2012-12-12 4 CAT CATERPILLAR INC
Common
G - Gift 294 294
2012-12-20 2012-12-12 4 CAT CATERPILLAR INC
Common
G - Gift -294 53,688 -0.54
2012-12-20 2012-12-12 4 CAT CATERPILLAR INC
Common
G - Gift -125 53,982 -0.23
2012-12-20 2012-11-30 4 CAT CATERPILLAR INC
Common
G - Gift -1,000 54,107 -1.81
2012-12-14 3 ABBV AbbVie Inc.
Common stock, $0.01 par value
0
2012-11-28 2012-11-26 4 CAT CATERPILLAR INC
Employee Stock Option
M - Exercise -13,500 0 -100.00
2012-11-28 2012-11-26 4 CAT CATERPILLAR INC
Common
F - Taxes -8,137 55,107 -12.87 84.40 -686,722 4,650,755
2012-11-28 2012-11-26 4 CAT CATERPILLAR INC
Common
M - Exercise 13,500 63,244 27.14 27.14 366,424 1,716,600
2012-08-01 2012-07-30 4 CAT CATERPILLAR INC
Employee Stock Option
M - Exercise -13,500 0 -100.00
2012-08-01 2012-07-30 4 CAT CATERPILLAR INC
Phantom Stock Units
A - Award 5,585 26,789 26.34
2012-08-01 2012-07-30 4 CAT CATERPILLAR INC
Common
S - Sale -13,500 49,732 -21.35 85.78 -1,157,976 4,265,812
2012-08-01 2012-07-30 4 CAT CATERPILLAR INC
Common
M - Exercise 13,500 63,232 27.15 27.14 366,424 1,716,275
2012-05-03 2012-05-01 4 CAT CATERPILLAR INC
Common
A - Award 2,500 49,714 5.30
2012-04-04 2012-04-02 4 CAT CATERPILLAR INC
Common
F - Taxes -208 47,214 -0.44 106.49 -22,150 5,027,819
2012-03-07 2012-03-05 4 CAT CATERPILLAR INC
Employee Stock Option (right to buy)
A - Award 60,515 60,515
2012-03-06 2012-03-02 4 CAT CATERPILLAR INC
Restricted Stock Units
M - Exercise -6,561 0 -100.00
2012-03-06 2012-03-02 4 CAT CATERPILLAR INC
Common
F - Taxes -2,720 45,134 -5.68 112.87 -307,006 5,094,275
2012-03-06 2012-03-02 4 CAT CATERPILLAR INC
Common
M - Exercise 6,561 47,854 15.89
2012-02-23 2012-02-21 4 CAT CATERPILLAR INC
Employee Stock Option
M - Exercise -27,000 27,000 -50.00 115.00 -3,105,000 3,105,000
2012-02-23 2012-02-21 4 CAT CATERPILLAR INC
Common
S - Sale -27,000 41,293 -39.54 115.00 -3,105,000 4,748,695
2012-02-23 2012-02-21 4 CAT CATERPILLAR INC
Common
M - Exercise 27,000 68,293 65.39 27.14 732,848 1,853,643
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)